Palivizumab: Difference between revisions
From IDWiki
(Created page with "* Monoclonal antibody to RSV * Targets the F subunit * Limited indications (refer to RSV for details) Category:Antivirals") |
No edit summary |
||
| Line 2: | Line 2: | ||
* Targets the F subunit |
* Targets the F subunit |
||
* Limited indications (refer to [[RSV]] for details) |
* Limited indications (refer to [[RSV]] for details) |
||
* Main side effect is anaphylaxis |
|||
* Cost about $5000 per patient per season, which reduces hospitalizations |
|||
[[Category:Antivirals]] |
[[Category:Antivirals]] |
||
